CA2200846A1 - Promoter for the receptor tyrosine kinase, tie - Google Patents
Promoter for the receptor tyrosine kinase, tieInfo
- Publication number
- CA2200846A1 CA2200846A1 CA002200846A CA2200846A CA2200846A1 CA 2200846 A1 CA2200846 A1 CA 2200846A1 CA 002200846 A CA002200846 A CA 002200846A CA 2200846 A CA2200846 A CA 2200846A CA 2200846 A1 CA2200846 A1 CA 2200846A1
- Authority
- CA
- Canada
- Prior art keywords
- tie
- tyrosine kinase
- receptor tyrosine
- promoter
- diagnosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
- C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present application discloses promoter sequences for Tie, an endothelial cell receptor tyrosine kinase and their use in therapy and diagnosis as well as production of proteins in blood and tissues.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US31071794A | 1994-09-22 | 1994-09-22 | |
US08/310,717 | 1994-09-22 | ||
PCT/FI1995/000520 WO1996009381A1 (en) | 1994-09-22 | 1995-09-22 | Promoter for the receptor tyrosine kinase, tie |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2200846A1 true CA2200846A1 (en) | 1996-03-28 |
CA2200846C CA2200846C (en) | 2007-05-01 |
Family
ID=38051343
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002200846A Expired - Fee Related CA2200846C (en) | 1994-09-22 | 1995-09-22 | Promoter for the receptor tyrosine kinase, tie |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2200846C (en) |
-
1995
- 1995-09-22 CA CA002200846A patent/CA2200846C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2200846C (en) | 2007-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO971341D0 (en) | Promoter for receptor tyrosine kinase TIE | |
CA2258153A1 (en) | Hepatocyte growth factor receptor agonists and uses thereof | |
CA2184584A1 (en) | Vascular endothelial growth factor 2 | |
EP2189475A3 (en) | Fibroblast growth factor-like polypeptides | |
CA2194369A1 (en) | Methods and compositions for the specific coagulation of vasculature | |
CA2026915A1 (en) | Stem cell factor | |
MX9702307A (en) | PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE. | |
CA2219988A1 (en) | Cd16-ii variants | |
IS2505B (en) | Reflective contrast agents, preferably long in the blood, for diagnostic purposes | |
CA2220008A1 (en) | Composition and method for tumor imaging | |
CA2071214A1 (en) | Method of delivering molecules into eukaryotic cells | |
EP2213302A3 (en) | DR4 antibodies and uses thereof | |
CA2387873A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
WO1996019580A3 (en) | Telomerase protein component | |
EP1571216A3 (en) | Phosphodiesterase 8A | |
CA2406057A1 (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
CA2255539A1 (en) | Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma | |
WO2000053749A3 (en) | Vascular adhesion molecules and modulation of their function | |
WO1996040743A3 (en) | Inhibitors of factor xa | |
EP1443055A3 (en) | Interleukins-21 and 22 | |
CA2298820A1 (en) | The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in photodynamic therapy and certain such novel derivatives | |
ES2177769T3 (en) | AMINOTETHRALINE DERIVATIVE FOR CARDIOVASCU LARES DISORDERS THERAPY. | |
AU1867297A (en) | Gene-therapeutic nucleic acid construct, production of same and use of same in the treatment of heart disorders | |
CA2200846A1 (en) | Promoter for the receptor tyrosine kinase, tie | |
CA2316447A1 (en) | Rantes mutants and therapeutic applications thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed | ||
MKLA | Lapsed |
Effective date: 20100922 |